References
- Allam JP, Novak N. The pathophysiology of atopic eczema. Clinical and Experimental Dermatology. 2006. 31: 89-93. https://doi.org/10.1111/j.1365-2230.2005.01980.x
- Berke R, Singh A, Guralnick M. Atopic dermatitis: an overview. American Family Physician. 2012. 86: 35-42.
- Bieber T. Atopic dermatitis. The New England Journal of Medicine. 2008. 358: 1483-1494. https://doi.org/10.1056/NEJMra074081
- Brenninkmeijer EE, Spuls PI, Legierse CM, Lindeboom R, Smitt JH, Bos JD. Clinical differences between atopic and atopiform dermatitis. Journal of the American Academy of Dermatology. 2008. 58: 407-414. https://doi.org/10.1016/j.jaad.2007.12.002
- Bunikowski R, Gerhold K, Brautigam M, Hamelmann E, Renz H, Wahn U. Effect of low-dose cyclosporin a microemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severe pediatric atopic dermatitis. International Archives of Allergy and Immunology. 2001. 125: 344-348. https://doi.org/10.1159/000053836
-
Choi IY, Kim SJ, Kim MC, Kim HL, Shin HJ, Kang TH, Jeong HJ, Shim JS, Kim JH, Yang DC, Hong SH, Kim HM, Um JY. Inhibitory effects of the transgenic Panax ginsengs on phorbol ester plus A23187-induced IL-6 production and cyclooxygenase-2 via suppression of NF-
${\kappa}B$ and MAPKs in HMC-1. Immunopharmacology And Immunotoxicology. 2011. 33: 205-210. https://doi.org/10.3109/08923973.2010.496459 - Das A, Panda S. Use of Topical Corticosteroids in Dermatology: An Evidence-based Approach. Indian Journal of Dermatology. 2017. 62: 237-250.
- Fedenko ES, Elisyutina OG, Filimonova TM, Boldyreva MN, Burmenskaya OV, Rebrova OY, Yarilin AA, Khaitov RM. Cytokine gene expression in the skin and peripheral blood of atopic dermatitis patients and healthy individuals. Self Nonself. 2011. 2: 120-124. https://doi.org/10.4161/self.2.2.16939
-
Gadaleta RM, Oldenburg B, Willemsen EC, Spit M, Murzilli S, Salvatore L, Klomp LW, Siersema PD, van Erpecum KJ, van Mil SW. Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-
${\kappa}B$ signaling in the intestine. Biochimica et Biophysica Acta. 2011. 1812: 851-858. https://doi.org/10.1016/j.bbadis.2011.04.005 - Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annual Review of Immunology. 2005. 23: 749-786. https://doi.org/10.1146/annurev.immunol.21.120601.141025
-
Gilmore TD, Garbati MR. Inhibition of NF-
${\kappa}B$ signaling as a strategy in disease therapy. Current Topics in Microbiology and Immunology. 2011. 349: 245-263. - Gold MS, Kemp AS. Atopic disease in childhood. The Medical Journal of Australia. 2005. 182: 298-304.
- Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Experimental Dermatology. 2001. 10: 11-18. https://doi.org/10.1034/j.1600-0625.2001.100102.x
- Harvima IT, Nilsson G. Mast cells as regulators of skin inflammation and immunity. Acta Dermato Venereologica. 2011. 91: 644-650. https://doi.org/10.2340/00015555-1197
- Kim SJ, Kim MC, Um JY, Hong SH. The beneficial effect of vanillic acid on ulcerative colitis. Molecules. 2010. 15: 7208-7217. https://doi.org/10.3390/molecules15107208
- Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003. 361: 151-160. https://doi.org/10.1016/S0140-6736(03)12193-9
- Minami K, Kamei CA. chronic model for evaluating the itching associated with allergic conjunctivitis in rats. International Immunopharmacology. 2004. 4: 101-108. https://doi.org/10.1016/j.intimp.2003.10.013
- Modena BD, Dazy K, White AA. Emerging concepts: mast cell involvement in allergic diseases. Translational Reserch. 2016. 174: 98-121. https://doi.org/10.1016/j.trsl.2016.02.011
- Mukaida N. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. International Journal of Hematology. 2000. 72: 391-398.
- Saeki H, Furue M, Furukawa F, Hide M, Ohtsuki M, Katayama I, Sasaki R, Suto H, Takehara K. Guidelines for management of atopic dermatitis. Journal of Dermatology. 2009. 36: 563-577. https://doi.org/10.1111/j.1346-8138.2009.00706.x
- Shiohara T, Hayakawa J, Mizukawa Y. Animal models for atopic dermatitis: are they relevant to human disease. Journal of Dermatological Science. 2004. 36: 1-9. https://doi.org/10.1016/j.jdermsci.2004.02.013
- Siraganian RP. Mast cell signal transduction from the high-affinity IgE receptor.Current Opinion in Immunology. 2003. 15: 639-646. https://doi.org/10.1016/j.coi.2003.09.010
- Tegeder I, Pfeilschifter J, Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB Jornal. 2001. 15: 2057-2072. https://doi.org/10.1096/fj.01-0390rev
- Trefzer U, Hofmann M, Sterry W, Asadullah K. Cytokine and anticytokine therapy in dermatology. Expert Opinion on Biological Therapy. 2003. 3: 733-743. https://doi.org/10.1517/14712598.3.5.733
-
Wan C, Yuan T, Cirello AL, Seeram NP. Antioxidant and
$\alpha$ -glucosidase inhibitory phenolics isolated from highbush blueberry flowers. Food Chemistry. 2012. 135: 1929-1937. https://doi.org/10.1016/j.foodchem.2012.06.056 - Wong CK, Ho CY, Ko FW, Chan CH, Ho AS, Hui DS, Lam CW. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clinical and Experimental Immunology. 2001. 125: 177-183. https://doi.org/10.1046/j.1365-2249.2001.01602.x
- Xu W, Zhou Q, Yao Y, Li X, Zhang JL, Su GH, Deng AP. Inhibitory effect of Gardenblue blueberry (Vaccinium ashei Reade) anthocyanin extracts on lipopolysaccharide-stimulated inflammatory response in RAW 264.7 cells. Journal of Zhejiang University Science B. 2016. 17: 425-436. https://doi.org/10.1631/jzus.B1500213
- Yoon HJ, Jang MS, Kim HW, Song DU, Nam KI, Bae CS, Kim SJ, Lee SR, Ku CS, Jang DI, Ahn BW. Protective effect of diet supplemented with rice prolamin extract against DNCBinduced atopic dermatitis in BALB/c mice. BMC Complementary and Alternative Medicine. 2015. 15: 353. https://doi.org/10.1186/s12906-015-0892-0